[New perspectives in the treatment of the motor complications associated with chronic treatment of Parkinson disease].
Linazasoro
G
G
Centro de Neurología y Neurocirugía funcional, Clínica Quirón, San Sebastián. Neurotax@jet.es
D000978:Antiparkinson Agents / Q000009:adverse effects*; D065098:Catechol O-Methyltransferase Inhibitors; D018491:Dopamine Agonists / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D018491:Dopamine Agonists